SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Marvells agreed all-stock acquisition of Lumentum is driving attention, with Lumentums fixed exchange ratio tying its deal value to Marvells share price. Traders are debating the deals value as LITE falls alongside MRVL, questioning whether the headline premium holds up as the acquirers stock weakens.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvells agreement to acquire Lumentum in an all-stock deal is the dominant focus, with traders concerned about shareholder dilution, financing, and integration risks as the stock sells off. Others see strategic value in combining Marvells AI-connectivity business with Lumentums optical technology, but debate how long the benefits may take to materialize.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

Buzz centers on reports that a POET optical engine appeared in Foxconns photonics ecosystem at Hon Hai Tech Day, which bulls view as validation of the FIT collaboration and POETs AI data-center optics opportunity. The display has not confirmed production orders or scaled shipments, leaving traders divided between optimism about commercialization and frustration over the lack of concrete customer updates ahead of earnings.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsomes third-quarter results beat expectations, with strong revenue growth led by Auvelity and a narrower-than-expected loss. Traders welcomed the report and see cash-flow break-even approaching, while the lack of formal guidance drew some concern.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals European Lithium acquisition is driving attention, with traders weighing greater ownership of Tanbreez and added assets against dilution and potential selling pressure from newly issued shares. High reported short interest and borrowing costs have fueled squeeze speculation, though the community is divided over whether the deal is ultimately bullish or a near-term overhang.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

CIFRs quarterly results are driving discussion, with traders criticizing weak revenue and ongoing cash-generation and financing concerns despite reported progress bringing HPC leases into service. The reaction is split between fears that debt and the miner-to-AI infrastructure transition will weigh on the stock and bullish arguments that contracted leases and continued AI demand support the longer-term case.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AIs Q3 results and higher full-year revenue guidance are driving discussion, with traders noting the reported EPS beat and asking whether the company is finally GAAP-positive. Despite the upbeat report, shares are lower, fueling debate over a sell-the-news reaction versus improving fundamentals.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A sharp breakout to fresh 52-week highs has drawn attention as traders focus on the upcoming Q3 report and BRIUMVIs commercial momentum. Buyout and short-squeeze theories are also prominent, but remain speculation; some traders attribute the move to earnings positioning and momentum instead.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

FDA accelerated approval of Inovios competing RRP treatment has focused attention on potential competition for Precigens PAPZIMEOS and prompted concern about its market position. Traders debate whether the rivals treatment regimen will pressure PAPZIMEOS or whether Precigens commercial head start, payer access, and full-approval status will help it retain an advantage.

Centrus Energy Corp. engages in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment includes various components of nuclear fuel to utilities from its global network of suppliers. The Technical Solutions segment offers advanced engineering, design, and manufacturing services to government and private sector customers, and is deploying advanced nuclear fuel production capabilities to power existing, and next-generation reactors around the world. The company was founded in October 1992 and is headquartered in Bethesda, MD.

Centrus Energy Corp - Ordinary Shares - Class A

Centrus Energy Corp 

LEU is drawing attention amid a steep, volatile selloff, with traders blaming the recent stock-and-warrant offering and potential dilution, while also debating high valuation and the cost and timeline of expanding enrichment capacity. Bulls point to DOE support, customer contracts and centrifuge production progress as reasons the long-term domestic nuclear-fuel opportunity remains intact, while others expect continued pressure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stocks making the biggest moves premarket: Ultralife, SK Hynix, Robinhood, Enphase Energy & more

These are the stocks posting the largest moves premarket...

12 Industrials Stocks Moving In Wednesday's Pre-Market Session

Gainers

Ultralife (NASDAQ:ULBI) shares moved upwards by 144.7% to $15.56 during Wednesday's pre-market session. The company's market cap stands at $105.9 million.
Elong Power Holding (NASDAQ:ELPW) shares movedread more...

ULBI Stock Alert: Halper Sadeh LLC is Investigating Whether Ultralife Corporation is Obtaining a Fair Price for its Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Ultralife Corporation (NASDAQ: ULBI) to EnerSys for $16.00 per share in cash.Halper Sadeh encourages Ultralife shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary...

ULBI SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES ULTRALIFE CORPORATION

ULBI SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES ULTRALIFE CORPORATION ULBI SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES ULTRALIFE CORPORATIONPR NewswireMILWAUKEE, Oct. 28, 2026 ULBI shareholders will receive just $16.00 per share in a...

Why Ultra Clean Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

Ultra Clean shares surged 14.6% after beating earnings and sales estimates; Ultralife soared 143.8% on a $320M acquisition deal.read more...

Why Did Ultralife (ULBI) Stock Shoot Up 145% in After-Hours Trading?

Ultralife shares surge 144.65% after hours as EnerSys agrees to acquire the battery maker for $320 million in cash.read more...

11 Industrials Stocks Moving In Tuesday's After-Market Session

Gainers

Ultralife (NASDAQ:ULBI) stock rose 144.0% to $15.52 during Tuesday's after-market session. The market value of their outstanding shares is at $100.1 million.
WF Holding (NASDAQ:WFF) shares rose 6.32% toread more...

EnerSys To Acquire Ultralife, Expanding Differentiated Battery Technologies and Accelerating Growth in Defense Market

EnerSys (NYSE: ENS), a global leader in stored energy solutions for industrial, infrastructure, and defense applications, today announced that it has entered into a definitive agreement to acquire Ultralife (NASDAQ:ULBI) for $16.00 per share in cash, representing a 166% premium to Ultralifes...

Ultralife Upgraded to Neutral on Backlog & Product Commercialization

ULBI's upgrade to Neutral reflects record backlog, product commercialization, manufacturing improvements and broader opportunities from vertical integration.

Ultralife Stock Gains Post Q2 Earnings Despite Y/Y Revenue Dip

ULBI's earnings improve in second-quarter 2026 despite softer revenues, as stronger margins, record backlog and operational gains supported its profitable-growth outlook.

Ultralife Corp. engages in the manufacture and sale of products for power solutions. It operates through the following segments: Battery and Energy Products and Communications System. The Battery and Energy Products segment includes Lithium 9-volt, cylindrical, thin cell and various other non-rechargeable batteries, in addition to rechargeable batteries, uninterruptable power supplies, charging systems, and accessories such as cables. The Communications System segment consists of radio frequency amplifiers, power supplies, cable and connector assemblies, amplified speakers, equipment mounts, case equipment, integrated communication systems for fixed or vehicle applications, and communications and electronics systems design. The company was founded by Arthur M. Liberman in December 1990 and is headquartered in Newark, NY.

Ultralife Corp

Ultralife Stock Pares Some Losses Following Q4 Profit Miss, Retail Banks On Future Growth

Equity

Bullish Sentiment

Ultralife Corp (ULBI) stock pared some losses in extended trade on Tuesday after its shares fell 6.1% in the regular session as its quarterly earnings missed Wall Street’s profit estimates.The battery solutions firm reported an adjusted income of $131,000, or $0.01 per share, for the three months ended Dec. 31, compared with $2.9 million, or $0.18 per share, a year earlier. Analysts were expecting it to post $0.15 per share in earnings.Its revenue fell to $43.9 million from $44.5 million a year earlier. However, Wall Street expected it to post $40 million in revenue.Its Battery &amp; Energy Products segment sales rose 11.7% to $39.9 million during the fourth quarter, compared to $35.7 million a year earlier, reflecting its acquisition of Electrochem.However, organic sales for the segment fell 5.3% as a 48.1% increase in government or defense sales and a 1.6% increase in oil &amp; gas market sales were offset by a 47.2% decrease in medical battery sales and a 4.4% decline in other industrial market sales.Communications Systems sales declined by 55.1% to $4 million as it shipped higher orders in the year-ago quarter.“For the fourth quarter, the contribution of Electrochem compensated for delays in the timing of expected larger orders for our Communications Systems segment and customer requests to push orders into 2025 for our Battery &amp; Energy Products segment,” said CEO Mike Manna.The company’s backlog and high-confidence orders stood at $102.2 million exiting 2024, compared to $78 million at the end of the third quarter.Retail sentiment on Stocktwits jumped to ‘bullish’ (64/100) territory from ‘bearish’(27/100) a day ago, while retail chatter surged to ‘extremely high.’<figure class="image"><img style="aspect-ratio:878/196;" src="https://news.stocktwits-cdn.com/ULBI_April_2_JPG_d38cff7582.webp" alt="ULBI’s Sentiment Meter and Message Volume as of 03:48 a.m. ET on April 2, 2025 | Source: Stocktwits" width="878" height="196"><figcaption>ULBI’s Sentiment Meter and Message Volume as of 03:48 a.m. ET on April 2, 2025 | Source: Stocktwits</figcaption></figure>One trader said even though the results were “mediocre,” the company maintained decent operating results “in what was clearly a tough environment.”<stembedurl>https://stocktwits.com/HTNY/message/609895163</stembedurl>Another trader saw margin improvements for the company following the $50 million acquisition of Electrochem.<stembedurl>https://stocktwits.com/richardred/message/609905891</stembedurl><a href="https://stocktwits.com/symbol/ULBI">Ultralife shares</a> have fallen nearly 33% year-to-date (YTD).Also See: <a href="https://stocktwits.com/news-articles/markets/equity/visa-in-focus-after-report-on-efforts-to-become-network-partner-for-apple-credit-cards/chf3ZGmRbIN">Visa Reportedly Aims To Power Apple Cards, But Retail Traders Stay Indifferent For Now</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Close up image of batteries. (Image Courtesy: Getty Images)

The battery solutions firm reported an adjusted income of $0.01 per share, while analysts expected $0.15 in earnings.

Ultralife Stock Pares Some Losses Following Q4 Profit Miss

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$15.62
Prev Close	$15.62
Open	$15.62
Dividend Yield	0.00%
50-Day Moving Average	$6.71
Beta	1.36
Avg. Volume	45,892.24
PE Ratio	-39.65

52-Week High	$15.67
52-Week Low	$4.90
Market Capitalization	$260.28M
EPS (Annual)	-$0.3544
Price to Book	1.96
Revenue Per Employee	$281,945.43

Feed

News

Sentiment

Earnings

Fundamentals

Info

ULBI Fundamentals